Timothy S. Cabral Sells 20,000 Shares of Doximity, Inc. (NASDAQ:DOCS) Stock

Doximity, Inc. (NASDAQ:DOCS) Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the sale, the director now directly owns 6,360 shares of the company’s stock, valued at approximately $366,463.20. The trade was a 75.87 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link.

Doximity Trading Up 0.7 %

Shares of Doximity stock opened at $58.58 on Friday. The firm has a market capitalization of $10.94 billion, a PE ratio of 67.33, a P/E/G ratio of 4.68 and a beta of 1.39. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $61.75. The firm’s 50-day moving average price is $55.09 and its 200 day moving average price is $45.31.

Doximity (NASDAQ:DOCS) last issued its quarterly earnings results on Thursday, November 7th. The company reported $0.24 earnings per share for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.02). The company had revenue of $136.83 million during the quarter, compared to analysts’ expectations of $127.05 million. Doximity had a net margin of 33.69% and a return on equity of 19.79%. During the same period in the prior year, the business posted $0.18 earnings per share. On average, sell-side analysts predict that Doximity, Inc. will post 0.88 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on DOCS. Bank of America raised their price target on Doximity from $54.00 to $57.00 and gave the stock a “neutral” rating in a research note on Monday, January 6th. KeyCorp dropped their price target on Doximity from $70.00 to $65.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 8th. Stephens initiated coverage on Doximity in a research note on Friday, December 20th. They issued an “equal weight” rating and a $55.00 price target on the stock. Mizuho initiated coverage on Doximity in a research report on Wednesday, December 4th. They set a “neutral” rating and a $55.00 target price on the stock. Finally, Raymond James reiterated an “outperform” rating and set a $65.00 target price (up from $37.00) on shares of Doximity in a research report on Friday, November 8th. Thirteen investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $53.12.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in DOCS. Handelsbanken Fonder AB raised its position in shares of Doximity by 0.7% during the 4th quarter. Handelsbanken Fonder AB now owns 29,700 shares of the company’s stock valued at $1,586,000 after buying an additional 200 shares during the period. UMB Bank n.a. raised its position in shares of Doximity by 69.1% during the 4th quarter. UMB Bank n.a. now owns 575 shares of the company’s stock valued at $31,000 after buying an additional 235 shares during the period. Fielder Capital Group LLC raised its position in shares of Doximity by 4.5% during the 4th quarter. Fielder Capital Group LLC now owns 5,488 shares of the company’s stock valued at $293,000 after buying an additional 235 shares during the period. GAMMA Investing LLC raised its position in shares of Doximity by 20.6% during the 4th quarter. GAMMA Investing LLC now owns 1,735 shares of the company’s stock valued at $93,000 after buying an additional 296 shares during the period. Finally, Steward Partners Investment Advisory LLC raised its position in shares of Doximity by 17.1% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 2,269 shares of the company’s stock valued at $121,000 after buying an additional 332 shares during the period. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.